Unjustified Restrictions on Letters to the Editor by Altman, Douglas G
PLoS Medicine  |  www.plosmedicine.org 0457
Correspondence
Open access, freely available online
Unjustiﬁ  ed Restrictions on Letters 
to the Editor 
Douglas G. Altman
Editors of medical journals accept that published research 
should be open to comment and correction in published 
correspondence ([1]; Box 1). “Post-publication peer 
review” enables comments on, clariﬁ  cations of, and 
corrections to published research. All journals should have a 
correspondence page for this purpose. 
I previously criticised the effective “statute of limitations” 
in several leading general medical journals “whereby authors 
of papers are immune to disclosure of methodological 
weaknesses once some arbitrary (short) period has elapsed” 
[2]. Such a time limit discourages post-publication peer 
review, with potential correspondents deterred by the short 
and unambiguous deadline. I suggested that journals with 
such a policy should reconsider. The word limit on that 
article precluded additional adverse comments on journals’ 
word limits for letters, although they were presented in Table 
2 of that article [2]. 
Subsequently, three of the six journals did revise their 
instructions [3–5], but each imposed tougher restrictions 
on letters, reducing either the maximum time limit, the 
maximum length, or both. The strictest current requirements 
are a two-week limit by The Lancet and a 175-word limit by the 
New England Journal of Medicine. 
Editors are seemingly falling over themselves to speed up 
and shorten letters, but this behaviour is inappropriate for a 
scientiﬁ  c journal. The key characteristic of science is not its 
infallibility, a quality it clearly does not and cannot have, but 
its self-correcting ability. The decision by medical editors to 
stiﬂ  e debate is misguided [2,6]. A time limit, especially a very 
short one, signals that speed is more important than content, 
that convenience takes precedence over science. While it is 
reasonable to encourage early comments, there should be no 
time limit on comments aimed at clarifying or criticising study 
methodology. Likewise, it will often be impossible to explain 
the subtleties of methodological problems in 400 words, and 
impossible in only 175. Additional restrictions on the number 
of authors and references are also questionable.
I am disappointed that PLoS Medicine has imposed a time 
limit of four weeks on correspondence. As explained above, 
I believe that such a limit is mistaken. The word limit of 
750 words is generous by comparison to established general 
medical journals, but even this should be open to ﬂ  exibility 
should the circumstances merit it. 
In this world of Web-based journals and Web pages for 
print journals there is no real cost to permitting longer and 
later letters on the web while keeping the print version timely 
and terse.  
Douglas G. Altman 
Cancer Research UK/NHS Centre for Statistics in Medicine
Oxford, United Kingdom
E-mail: doug.altman@cancer.org.uk
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Editors’ Reply
We agree with Doug Altman that correspondence is an 
essential part of medical publishing—acting as post-
publication peer review. Hence, we encourage submission 
of letters in response to articles we publish, preferably as 
e-letters via our Web site (www.plosmedicine.org) rather 
than via our manuscript submission site. The four-week 
limit we originally suggested in our author guidelines was 
to encourage timely correspondence; however, we accept 
that there will be occasions when it will be appropriate for 
letters to be published later than that, and we will accept such 
submissions. The word limit is more debatable. We think 
that 750 words is a reasonable limit; any more, and letters are 
likely to stray off the topic.  
Virginia Barbour, Barbara Cohen, Gavin Yamey
E-mail: medicine_editors@plos.org
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Box 1. “Editors Should Promote Self-Correction 
in Science and Participate in Efforts to Improve 
the Practice of Scientiﬁ  c Investigation by: 
•“Publishing corrections, retractions, and letters critical of articles 
published in their own journal.
•“Playing an active role in investigating and preventing fraud.
•“Taking responsibility for improving the level of scientiﬁ  c 
investigation and medical writing in the larger community of 
potential authors.
•“Giving authors an opportunity to review and approve edited 
manuscripts before they are published.
•“Participating in efforts to detect and prevent publication 
bias—for example, by collaborating with registries of controlled 
trials and publishing protocols.”
Source: [1].PLoS Medicine  |  www.plosmedicine.org 0458
Association between Injections 
and HIV Incidence
Naveed Zafar Janjua, Khabir Ahmad, Arshad Altaf, 
Mohammad Imran Khan, Hasan Bin Hamza
The article by Lopman and colleagues [1] has created more 
controversy than it’s cured. Their conclusion that unsafe 
injections “do not play a major role in the transmission of 
HIV in rural Zimbabwe” cannot be based on the data they 
have presented. There are many major problems with their 
conclusions.  
First, they did not assess at all whether injections received 
by the participants in the study were safe or unsafe. All they 
assessed was whether participants had received an injection 
or had been pricked by a needle during the past three years. 
The possibility that most of the injections in the setting were 
“safe” cannot be ruled out, and the data presented did not in 
any way address the issue of an association between “unsafe 
injection” practices and HIV infection.  
Second, the recall period used by the investigators was 
too long. Cognizant of this problem, the World Health 
Organization has been proposing a three-month recall 
period for assessing frequency of injections. Although this 
recall period is 12 times shorter than the one used by the 
authors, we found in our studies in Pakistan that, even then, 
people had great difﬁ  culties recalling injections. It must be 
mentioned that injections are very frequent procedures in 
Pakistan [2]. 
Third, it seems that aside from injections, the investigators 
have included only data from sexual histories in their study; 
hence, other potential sources of exposure such as minor 
and major surgical procedures, dental instrumentation, and 
tattooing or other traditional practices involving scariﬁ  cation 
have been missed.  
Fourth, it is not clear how “needle prick” was deﬁ  ned. Solid 
needles are also considered needles, but injury caused by 
these is less likely to transmit HIV than that caused by hollow 
bore needles.  
Fifth, the authors have failed to quantify exposure. 
The risk of contracting HIV increases as the number of 
unsafe injections increases [3]. The incidence of disease 
among people who received one injection during follow-up 
compared with those who received 20 injections would clearly 
be different. This relationship has been clearly seen in the 
case of hepatitis C infection [4]. 
Sixth, the authors recommend that policymakers “should 
concentrate more on trying to prevent infection from unsafe 
sex” than on injections. But they have failed to assess whether 
the sex was unsafe or otherwise.  
Further, we believe that even if the methodology is 
considered absolutely ﬂ  awless, the current conclusion can 
only apply to a particular population and geographic area 
because the proportion of disease attributable to various 
exposures depends on the relative distribution of exposures 
in the population. For example, it is argued that in India 
(with the world’s second largest HIV/AIDS population, 
more than 5 million) the HIV epidemic started as a result 
of high-risk sexual behaviors, but the number of injections 
per person is high and reuse of syringes in the health-care 
sector is widespread (N. K. Arora, personal communication). 
Therefore, unsafe medical injections have the potential to 
propagate this epidemic. Also, injections transmit many other 
pathogens like hepatitis B virus and hepatitis C virus. The 
infections that they cause have a very high morbidity and 
mortality. Hence, the need and urgency of intervention to 
decrease the overuse of injections and improve the safety of 
desired injections should not be questioned. Each country 
should make appropriate allocation of resources according to 
its own needs.  
Naveed Zafar Janjua (naveed.janjua@aku.edu)
Khabir Ahmad
Arshad Altaf
Mohammad Imran Khan
Hasan Bin Hamza
Aga Khan University
Karachi, Pakistan
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HIV Epidemiology in Africa: Weak 
Variables and Tendentiousness 
Generate Wobbly Conclusions
Stuart Brody, John J. Potterat
In their attempt to defend heterosexual transmission 
as the driving force for HIV epidemics in sub-Saharan 
Africa and dismiss the evidence for unsafe injections (or 
other percutaneous exposures) as a major source of HIV 
transmission [1,2], Lopman and colleagues [3] assert that 
“unsafe medical injections can be conﬁ  dently excluded as a 
major source of HIV infection” in Manicaland, Zimbabwe. 
Their methods and results are glaringly insufﬁ  cient to 
generate the conﬁ  dence they seek. Conﬁ  dence requires 
thorough evaluation, which was not done in their study [3]. 
Although the authors quantiﬁ  ed the number of sexual 
partners, they failed to quantify the number of injections 
[3], which undermines the likelihood of detecting an effect 
of injections, as does adding the statistical noise of “needle 
pricks” (how was that question phrased?) to injections. We 
ﬁ  nd it difﬁ  cult to believe that the authors were unaware 
of either the dose-dependency issue or the implications of 
using a weak measure of a vector that they are transparently 
invested in dismissing. In addition, the recall interval was 
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inordinately long (up to three years). It is unreasonable to 
expect accurate data from subjects who are not multiply 
prompted to stimulate recall.
As a secondary issue, their adjustment of the risk ratio 
associating HIV with injections against age is problematic. 
Adjusting a causal variable against age (which is a proxy for 
causal variables) may reduce the true association. Their Table 
1 shows that injections in women vary by age in the same 
pattern that HIV incidence varies by age. It might be that 
when they adjust for age, the risk ratios for age capture the 
association, leaving a diminished association for injections. 
Conﬁ  dence in their report is also undermined by their 
approach to their own ﬁ  nding that sexual behavior was 
unrelated to risk of incident HIV. Indeed, using the same 
standard of evidence that the authors applied to their null 
medical-injection ﬁ  nding, the abstract, discussion, and press 
release information should also have proclaimed that sex was 
“conﬁ  dently excluded” as a risk for HIV. Indeed, this would 
be consistent with the largest studies of HIV risk in Africa, 
including one in their own backyard (Manicaland) [4], 
which found little association of measured sexual behaviors 
with HIV risk. It would also be consistent with the many 
intervention studies reporting no beneﬁ  t from condom-
promotion programs [5], as well as with observation of the 
opposite trajectories of the HIV and STD epidemics observed 
in Zimbabwe [6].
Of additional concern is Lopman et al.’s ﬁ  nding that 13 of 
67 individuals who seroconverted reported no sexual partners 
in the long inter-survey period. Indeed, their Table 2 data 
show that women with no reported sexual partners have 
higher HIV incidence than women who report any partner 
during the three-year interval (1.56 HIV cases per 100 person-
years [12/770] for the former compared to 1.21 [36/2975] 
for the latter). They reveal their a priori conviction by forcing 
this datum into the procrustean sexual bed, inferring that 
it is explainable by unreported sexual activity rather than 
unreported or unmeasured percutaneous exposure. The 
authors blame underreporting of sexual behavior without 
using techniques shown to dramatically improve valid 
reporting [7]. 
Despite this remarkable lack of association in their women 
respondents between HIV incidence and number of sexual 
partners, they counterintuitively suggest (in the patient 
summary) that the important issue is sexual transmission. It 
seems to us that if sex doesn’t appear to explain high HIV 
incidence, then one should recommend looking for what 
does, which the authors do not do. Rather than relying 
on the case-control approach, what is needed is intensive 
contact tracing (with viral sequencing of HIV specimens 
from index cases and their infected contacts to elucidate 
transmission relationships [8]) and a rigorous inventory 
of possible exposures and vectors [7]. The contact tracing 
and conscientious environmental risk probing of recent 
public-health responses to avian inﬂ  uenza and severe acute 
respiratory syndrome are an example of a useful and superior 
step to the case-control approach. 
In brief, what is truly driving HIV transmission in sub-
Saharan Africa will not be resolved by hastily implemented 
weak variables or by dismissive comments about Africans’ 
self-reports of sexual behavior, especially comments 
unencumbered by data. Africans, science, and public health 
deserve better research [7].  
Stuart Brody (stuartbrody@hotmail.com)
University of Paisley
Paisley, Scotland
John J. Potterat
Colorado Springs, Colorado, United States of America
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Authors’ Reply: Don’t Let the Hypothesis Slip
In 2003, Brody and colleagues called for researchers to 
publish analyses investigating the hypothesised importance 
of medical injections in the transmission of HIV in Africa 
[1,2]. Considering the general failure of HIV/AIDS control 
programs and the neglect of this subject, we believed they 
were right to raise this controversial hypothesis, so we added 
a question to our ﬁ  eld survey and performed a fresh analysis 
to test the strength of association between injections and HIV 
incidence [3]. Therefore, we are disappointed that Brody 
and Potterat think that we are “transparently invested in 
dismissing” the hypothesis [2].
Now that pertinent incidence data (where the timing of 
exposure and event can be determined) have been published 
for Manicaland, Zimbabwe, and Rakai, Uganda, and have 
shown a lack of association with injections, we think it is 
unfair to belittle the difﬁ  culty of collecting data and to claim 
that we have not gone to great lengths to collect high-quality 
data on sexual behaviour [3,4]. On the contrary, because 
of the general problems in generating reliable responses to 
questions about sexual behaviour [5,6], the Manicaland HIV/
STD Prevention study has pioneered the use of informal, 
conﬁ  dential voting interview methods [6]. Brody and Potterat 
state that we found “that sexual behaviour was unrelated to 
risk of incident HIV”. However, in women, having a history 
of STD symptoms, having multiple sexual partners, or being 
widowed/separated/divorced (a proxy that a previous sexual 
partner died of HIV) were associated with HIV incidence. In 
men, the associations of HIV and sexual behaviour did not 
reach statistical signiﬁ  cance because of the small number of 
seroconversions. 
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It is true that women with one reported sex partner did 
not have a higher incidence than women with no reported 
partners. However, Brody and Potterat fail to point out that 
women with multiple sex partners had the highest incidence 
(31.3 cases per 1,000 person-years) and that rates were lower 
in men with no sex partners (3.1) than in those with one 
sex partner (13.6) or multiple sex partners (14.9). These 
analyses were performed on only a subset of the Manicaland 
cohort, but other publications have demonstrated the 
role of sexual behaviours as risk factors for HIV in this 
population [7]. 
We agree that our measure of injections was not 
perfect, and Brody and Potterat reiterate many of the 
limitations discussed in our paper: we used a binary 
(yes/no) measure of exposure, which did not capture the 
number of injections and had a fairly long follow-up period 
of three years. These dimensions are being measured 
in the next round of the cohort study. In the published 
data, it is possible that some cases had their exposure 
misclassiﬁ  ed, but as many as 40 (60%) of the individuals who 
seroconverted reported not to have received an injection. 
Post hoc power calculations (Figure 1) demonstrate that 
if there was a risk of 2.27 associated with injections, the 
ﬁ  nding would have been statistically signiﬁ  cant. The crude 
rate ratio for both sexes was 1.1 (95%; conﬁ  dence interval: 
0.7–1.8), which is not evidence that injections are a major 
transmission route of HIV. 
Brody and Potterat also claim that our statistics are ﬂ  awed 
because we controlled for age in the analysis. This is a moot 
point. We presented both univariable and age-adjusted rate 
ratios of injection exposure—neither showed an association.  
We ﬁ  nd it strange that Brody and Potterat reference 
themselves for a study performed in our “own backyard”, 
which was actually the baseline survey for our current study, 
and then mislead by saying that it shows little association 
between sexual behaviour and HIV risk. Lifetime number of 
sexual partners was in fact a very strong determinant of HIV 
status in this population [6,7]. 
In their separate response, Naveed Zafar Janjua and 
colleagues point out a number of important aspects 
concerning injection epidemiology and health care–
associated infections [8]. First, there is, by deﬁ  nition, a 
difference between safe and unsafe injections. Second, 
heightened risks may be associated with “minor and major 
surgical procedures, dental instrumentation, and tattooing or 
other traditional practices involving scariﬁ  cation”. (Although 
not part of our original report, 16 HIV-negative individuals 
reported to have received a blood transfusion in the follow-
up period. None of them seroconverted.) Third, a “needle 
prick” is a general term that captures lacerations with solid 
needles as well as those with a borehole. And fourth, the risk 
associated with receiving one injection is not the same as 
that for multiple injections, with certain types of injections 
carrying more risk than others.  
However, these concerns expressed by Janjua et al. are 
not pertinent to the hypothesis that we were testing: are 
injections a major route of transmission of HIV in this 
population in Manicaland Province in Zimbabwe? This 
analysis was motivated by the arguments of Gisselquist et 
al. that injections are the main driver of HIV transmission 
in southern Africa [1]. To be clear—we were not testing 
whether exposure to contaminated needles is a risk factor 
(clearly it is), whether certain types of injections carry more 
risk than others (clearly they do), or whether needles are a 
driver of the epidemic in certain populations in the world 
(clearly they are). The fact that there is no evidence of 
association between receipt of injections (of any number) 
and HIV incidence, before and after controlling for 
confounding variables, allows us to conclude that injections 
“do not play a major role in the transmission of HIV in rural 
Zimbabwe”[3].
The global HIV problem is not a single epidemic. In 
eastern Europe, over 50% of HIV infections are among users 
of injection drugs [9]; in Pakistan, people receive on average 
eight injections per year compared with about one in sub-
Saharan Africa [10]. Our ﬁ  ndings apply to Manicaland and 
may be relevant for similar epidemic patterns in southern 
Africa. They are not generalisable to all locations, but they do 
refute the hypothesis that HIV is transmitted through medical 
injections in the study population.  
Ben A. Lopman (b.lopman@imperial.ac.uk)
Geoff P. Garnett
Imperial College London
London, United Kingdom
Simon Gregson
Imperial College London
London, United Kingdom
Biomedical Research and Training Institute
Harare, Zimbabwe
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Figure 1. Plot of the Detectable Rate Ratio as a Function of Sample Size
Assuming power of 90% at the 95% signiﬁ  cance level [11], a rate 
ratio of 2.27 or greater would have achieved a signiﬁ  cant result 
given the 5,500 years of observation in the sample:
Sample size = 2
where u = 1.28, which is the one-sided percentage point of the 
normal distribution corresponding to 100% minus the power; 
v = 1.96, which is the percentage point of the normal distribution 
corresponding to the two-sided signiﬁ  cance level; and µ1 and 
µ2 are the seroconversion rates in exposed and unexposed 
individuals, respectively.
(u + v)2(µ1 + µ0)
(µ1 - µ0)2PLoS Medicine  |  www.plosmedicine.org 0461
Peter R. Mason
Biomedical Research and Training Institute
Harare, Zimbabwe
References
1.  Gisselquist D, Potterat JJ, Brody S, Vachon F (2003) Let it be sexual: How 
health care transmission of AIDS in Africa was ignored. Int J STD AIDS 14: 
148–161.
2.  Brody S, Potterat JJ (2005) HIV epidemiology in Africa: Weak variables and 
tendentiousness generate wobbly conclusions. PLoS Med 2: e137. DOI: 
10.1371/journal.pmed.0020137
3.  Lopman BA, Garnett GP, Mason PR, Gregson S (2005) Individual level 
injection history: A lack of association with HIV incidence in rural 
Zimbabwe. PLoS Med 2: e37. DOI: 10.1371/journal.pmed.0020037
4.  Kiwanuka N, Gray RH, Serwadda D, Li X, Sewankambo NK, et al. (2004) 
The incidence of HIV-1 associated with injections and transfusions in a 
prospective cohort, Rakai, Uganda. AIDS 18: 342–344.
5.  Cleland J, Boerma JT, Carael M, Weir SS (2004) Monitoring sexual 
behaviour in general populations: A synthesis of lessons of the past decade. 
Sex Transm Infect 80 (Suppl 2): 1–7.
6.  Gregson S, Mushati P, White PJ, Mlilo M, Mundandi C, et al. (2004) 
Informal conﬁ  dential voting interview methods and temporal changes in 
reported sexual risk behaviour for HIV transmission in sub-Saharan Africa. 
Sex Transm Infect 80 (Suppl 2): 36–42.
7.  Gregson S, Nyamukapa CA, Garnett GP, Mason PR, Zhuwau T, et al. (2002) 
Sexual mixing patterns and sex-differentials in teenage exposure to HIV 
infection in rural Zimbabwe. Lancet 359: 1896–1903.
8.  Janjua NZ, Ahmad K, Altaf A, Khan MI, Hamza HB (2005) Association 
between injections and HIV incidence. PLoS Med 2: e139. DOI: 10.1371/
journal.pmed.0020139
9.  Dehne KL, Khodakevich L, Hamers FF, Schwartlander B (1999) The HIV/
AIDS epidemic in eastern Europe: Recent patterns and trends and their 
implications for policy-making. AIDS 13: 741–749.
10. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M (1999) Unsafe injections 
in the developing world and transmission of bloodborne pathogens: A 
review. Bull World Health Organ 77:  789–800.
11. Kirkwood BR, Sterne JAC (2003) Essential medical statistics. Oxford: 
Blackwell Publishing. 288 p.
Citation: Lopman BA, Garnett GP, Mason PR, Gregson S (2005) Authors’ reply: Don’t 
let the hypothesis slip. PLos Med 2(5): e147.
Copyright: © 2005 Lopman et al. This is an open-access article distributed under 
the terms of the Creative Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original work is 
properly cited.
Competing Interests: GPG has acted as a consultant for and/or received grants 
from GlaxoSmithKline, Aventis Pasteur, Merck, and Abbott Pharmaceuticals. GPG 
also chaired a meeting of the World Health Organization in 2003 to develop a 
consensus on the importance of unsafe injections in HIV epidemiology. SG owns 
shares in GlaxoSmithKline Beecham and Astra Zeneca. 
DOI: 10.1371/journal.pmed.0020147
Fundamental Limits to the Precision 
of Early Warning Systems for Epidemics 
of Infectious Diseases
John M. Drake
The development of early warning systems (EWSs) for 
epidemics of infectious diseases based on recurrent statistical 
patterns in other kinds of information, particularly data on 
climate, is an active area of research [1,2]. Judging from 
the estimated burden of diseases for which EWSs might 
be developed, such systems, if effective, would contribute 
greatly to human welfare and could potentially save many 
lives [2]. According to a recent report [2], EWSs have two 
principal aims: (i) to identify whether an epidemic will occur 
and (ii) to predict the number of cases that will result from 
it. For directly transmitted diseases, this second aim may be 
unattainable at the desired levels of precision, regardless of 
the quality of information.
As an example, in a recent report on the relationship 
between climate and outbreaks of meningococcal meningitis, 
the authors found that the timing of epidemics is highly 
predictable from information on the dynamics of a seasonal 
weather pattern, the Harmattan winds, but that the ﬁ  nal 
epidemic size is not [1]. This ﬁ  nding is not surprising. The 
characteristics of disease outbreaks, particularly outbreaks of 
emerging diseases to which human populations are highly 
susceptible, prevent highly precise forecasts.
The reason that precise estimates of the ﬁ  nal epidemic 
size cannot be obtained can be understood intuitively. 
Consider the following description of a typical outbreak. 
Characteristically, an outbreak begins with a small 
number of initially infectious individuals. Subsequent 
infectious contacts are mediated by a wide range of social 
interactions—contacts within and among households and 
communities—so that even individuals that are virtually 
identical can differ considerably in the number of secondary 
infections they cause. This is a micro-scale cause of variation 
compared with macro-scale, population-level sources of 
variation. The important implication for EWSs is that in 
such situations, especially where the basic reproductive 
ratio of infections (R0) is initially very high but is rapidly 
reduced (perhaps by public-health interventions), small 
deviations in the realized number of infectious contacts 
are ampliﬁ  ed, resulting in relatively large variation in the 
ﬁ  nal size of the outbreak. Because this variation reﬂ  ects 
differences in individual behavior and not macroscopic 
characteristics of epidemic spread, it is unlikely that climate 
or other data contain any information about this source of 
variation (though such data do contain information about 
macroscopic variation).
A more formal explanation of this phenomenon can 
be formulated based on a simple model of an epidemic 
in which an EWS captures all macroscopic causes of 
variation in the ﬁ  nal epidemic size but no microscopic 
causes. Obviously, an EWS cannot realistically be expected 
to capture even all the macroscopic information. Thus, 
this limit to precision is a fundamental limit and should 
be interpreted as a theoretical upper bound on forecast 
precision. The simplest case considers a disease with 
only two macroscopic epidemiological characteristics, 
an infection rate and a removal rate, which may change 
over time as in the case of meningococcal meningitis. In 
particular, we assume that there is no immunity in the 
population and that infection and removal are independent 
in time. This model of disease dynamics belongs to a class of 
stochastic processes known as nonhomogenous birth–death 
processes, which, conveniently, turn out to be reasonably 
tractable. More than 50 years ago, Kendall [3] showed how 
models for the mean and the variance in the ﬁ  nal epidemic 
size are affected by these parameters. The variance can 
be interpreted as a measure of the precision with which 
the ﬁ  nal epidemic size can be predicted. Kendall’s results 
can be broken down to show that this quantity is equal to 
the sum of the average ﬁ  nal epidemic size and another 
quantity (x) minus one. For most realistic epidemiological 
parameters, this other quantity, which is related to the 
covariance between ﬁ  nal epidemic size and the size of the 
infected population, will be much greater than one. In these 
cases, the variance in the ﬁ  nal epidemic size will be much 
greater than the average ﬁ  nal epidemic size itself.
This fundamental limit to the precision of forecasts 
does not imply that EWSs cannot be used effectively to 
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plan a response to outbreaks. Rather, it suggests what 
expectations of EWSs are reasonable. Further, since the 
precision with which forecasts of the ﬁ  nal epidemic size can 
be obtained will depend on many disease-speciﬁ  c properties 
and maybe other factors, too, case studies of the potential 
effectiveness of EWSs for different diseases are needed. 
These studies should exploit recent advances in modeling 
birth–death processes [4] to gain further understanding 
of the differences among diseases and of the causes of 
geographic variation in the intensity of epidemics. Finally, 
notwithstanding limits to precision, the beneﬁ  ts to be 
obtained from estimates of the average ﬁ  nal epidemic size 
and the timing of epidemics alone may warrant considerable 
investment in EWSs.  
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